CYTOSORBENTS CORP's ticker is CTSO and the CUSIP is 23283X206. A total of 72 filers reported holding CYTOSORBENTS CORP in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $53,000 | -24.3% | 16,730 | 0.0% | 0.00% | – |
Q4 2021 | $70,000 | -50.0% | 16,730 | -2.9% | 0.00% | – |
Q3 2021 | $140,000 | +7.7% | 17,229 | 0.0% | 0.00% | – |
Q2 2021 | $130,000 | -20.2% | 17,229 | -8.3% | 0.00% | – |
Q1 2021 | $163,000 | +15.6% | 18,791 | +6.3% | 0.00% | – |
Q4 2020 | $141,000 | +38.2% | 17,679 | +38.1% | 0.00% | – |
Q3 2020 | $102,000 | -12.1% | 12,803 | +9.3% | 0.00% | – |
Q2 2020 | $116,000 | -11.5% | 11,711 | -31.0% | 0.00% | – |
Q1 2020 | $131,000 | +70.1% | 16,979 | -14.8% | 0.00% | – |
Q4 2019 | $77,000 | +4.1% | 19,921 | +35.6% | 0.00% | – |
Q3 2019 | $74,000 | -23.7% | 14,693 | 0.0% | 0.00% | – |
Q2 2019 | $97,000 | +2.1% | 14,693 | +16.9% | 0.00% | – |
Q1 2019 | $95,000 | -6.9% | 12,570 | 0.0% | 0.00% | – |
Q4 2018 | $102,000 | -26.6% | 12,570 | +16.8% | 0.00% | – |
Q3 2018 | $139,000 | – | 10,766 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
CM Management, LLC | 450,000 | $846,000 | 0.90% |
Skylands Capital, LLC | 2,944,670 | $5,535,980 | 0.84% |
Sargent Investment Group, LLC | 1,257,048 | $2,363,250 | 0.57% |
JACOB ASSET MANAGEMENT OF NEW YORK LLC | 197,940 | $372,127 | 0.52% |
Avenir Corp | 2,717,397 | $5,108,706 | 0.48% |
Granahan Investment Management | 1,552,393 | $2,918,499 | 0.10% |
Seelaus Asset Management LLC | 20,450 | $38,446 | 0.04% |
HighMark Wealth Management LLC | 10,000 | $18,800 | 0.02% |
Key Client Fiduciary Advisors, LLC | 13,000 | $24,440 | 0.02% |
Eudaimonia Partners, LLC | 23,500 | $44,180 | 0.01% |